Avadel Pharmaceuticals Plc financial data

Symbol
AVDL on Nasdaq
Industry
Pharmaceutical Preparations
Location
Block 10 1 Blanchardstown Corporate Park, Ballycoolin, Dublin, Ireland
Fiscal year end
December 31
Former names
FLAMEL TECHNOLOGIES SA (to 12/30/2016)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 323 % +60.1%
Quick Ratio 15.3 %
Debt-to-equity 75.6 %
Return On Equity -150 % -120%
Return On Assets -85.2 % +13.4%
Operating Margin -246 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.1M shares +49.1%
Common Stock, Shares, Outstanding 96.1M shares +49%
Entity Public Float 1.46B USD +926%
Common Stock, Value, Issued 960K USD +49.1%
Weighted Average Number of Shares Outstanding, Basic 91.7M shares +43.5%
Weighted Average Number of Shares Outstanding, Diluted 91.7M shares +43.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 55.1M USD
Research and Development Expense 12.5M USD -28.7%
Costs and Expenses 144M USD +46.3%
Operating Income (Loss) -136M USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -157M USD -39.8%
Income Tax Expense (Benefit) 172K USD -99.4%
Net Income (Loss) Attributable to Parent -157M USD -10.6%
Earnings Per Share, Basic -1.82 USD/shares +21.6%
Earnings Per Share, Diluted -1.82 USD/shares +21.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.8M USD -57.1%
Marketable Securities, Current 53M USD +202%
Accounts Receivable, after Allowance for Credit Loss, Current 22.7M USD
Inventory, Net 11.9M USD
Other Assets, Current 3.32M USD +513%
Assets, Current 136M USD +24.3%
Property, Plant and Equipment, Net 526K USD -32.7%
Operating Lease, Right-of-Use Asset 2.37M USD +60.9%
Goodwill 16.8M USD 0%
Other Assets, Noncurrent 11.8M USD +7.66%
Assets 168M USD +19.3%
Accounts Payable, Current 19M USD +89.2%
Accrued Liabilities, Current 27.6M USD +260%
Liabilities, Current 47.8M USD -39.8%
Operating Lease, Liability, Noncurrent 1.45M USD +127%
Other Liabilities, Noncurrent 5.93M USD +2.74%
Liabilities 89.5M USD -50%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23.8M USD +8.72%
Retained Earnings (Accumulated Deficit) -773M USD -25.5%
Stockholders' Equity Attributable to Parent 78.4M USD
Liabilities and Equity 168M USD +19.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD +1.75%
Net Cash Provided by (Used in) Financing Activities 13.2M USD -61.7%
Net Cash Provided by (Used in) Investing Activities 21.4M USD +322%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.1M shares +49%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.63M USD -50.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.8M USD -57.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 730K USD -76.1%
Deferred Tax Assets, Valuation Allowance 96.4M USD +35.2%
Deferred Tax Assets, Gross 96.4M USD +35%
Operating Lease, Liability 2.62M USD +50.8%
Depreciation 254K USD +56.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -155M USD -8.23%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD +66.1%
Operating Lease, Liability, Current 953K USD +9.41%
Lessee, Operating Lease, Liability, to be Paid, Year Two 683K USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.09M USD +7.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +60%
Deferred Income Tax Expense (Benefit) 160K USD -99.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 420K USD +352%
Lessee, Operating Lease, Liability, to be Paid, Year Three 477K USD +132%
Deferred Tax Assets, Operating Loss Carryforwards 71.1M USD +33.1%
Preferred Stock, Shares Issued 0 shares -100%
Deferred Federal Income Tax Expense (Benefit) 0 USD -100%
Current Income Tax Expense (Benefit) -661K USD
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 3.04M USD -3.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 477K USD
Operating Lease, Payments 1.04M USD +7.58%
Preferred Stock, Shares Outstanding 0 shares -100%
Current State and Local Tax Expense (Benefit) -661K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 15.8M USD +125%
Deferred State and Local Income Tax Expense (Benefit) 160K USD +24%
Interest Expense 12.3M USD +24.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%